Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Telomerase inhibitors

Telomerase inhibitors

US Patent 5760062 · Granted Jun 2, 1998

Estimated economic value: $4,111,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of extracellular signal-regulated kinase2025
Telomerase reverse transcriptase (TERT) expression enhancing compounds and metho2025
Substituted naphthyl P38alpha mitogen-activated protein kinase inhibitors2025
Crystalline 5-(dimethylamino)-N-(4-(morpholinomethyl) phenyl)naphthalene-1-sulfo2025
8-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (2024
Crystalline chloro-n-(4-(morpholinomethyl)phenyl)benzamide and crystalline hydro2024
Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitors2024
P38α mitogen-activated protein kinase inhibitors2024
Immunomodulator antibody drug conjugates and uses thereof2023
8-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (2023
Substituted naphthyl p38α mitogen-activated protein kinase inhibitors2023
p38α mitogen-activated protein kinase inhibitors2022